MicroVision (NASDAQ: MVIS) executive buys 93,950 shares from company

Rhea-AI Filing Summary

MicroVision, Inc. Executive Vice Chair Simon Biddiscombe acquired 93,950 shares of the company’s common stock on March 15, 2026. The shares were purchased directly from MicroVision under a Subscription Agreement at $0.5322 per share, the closing price on March 13, 2026, in a transaction intended to be exempt under Rule 16b-3. Following this acquisition, Biddiscombe directly holds 385,249 MicroVision shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BIDDISCOMBE SIMON

(Last) (First) (Middle)

18390 NE 68TH STREET

(Street)

REDMOND WA 98052

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MICROVISION, INC. [ MVIS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Vice Chair

3. Date of Earliest Transaction (Month/Day/Year)
03/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	03/15/2026		A(2)		93,950	A	$0.5322	385,249	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Pursuant to a Subscription Agreement executed on March 15, 2026 between MicroVision, Inc. ("MicroVision") and the reporting person, the reporting person acquired 93,950 shares of MicroVision's common stock directly from MicroVision at a purchase price of $0.5322 per share, the closing price of MicroVision's common stock on March 13, 2026.

2. The purchase is intended to be an exempt transaction pursuant to Rule 16b-3.

	/s/ Drew G. Markham, attorney-in-fact for Simon Biddiscombe	03/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did MicroVision (MVIS) report for Simon Biddiscombe?

MicroVision reported that Executive Vice Chair Simon Biddiscombe acquired 93,950 shares of common stock. The shares were obtained directly from the company under a Subscription Agreement at $0.5322 per share, increasing his direct holdings to 385,249 shares.

At what price did Simon Biddiscombe acquire MicroVision (MVIS) shares?

Simon Biddiscombe acquired MicroVision shares at $0.5322 per share. This price matches the closing price of MicroVision’s common stock on March 13, 2026, as referenced in the Subscription Agreement governing the transaction.

How many MicroVision (MVIS) shares does Simon Biddiscombe hold after this Form 4 transaction?

After the reported acquisition, Simon Biddiscombe directly holds 385,249 shares of MicroVision common stock. This total reflects the addition of 93,950 shares purchased from the company under the March 15, 2026 Subscription Agreement.

Was the MicroVision (MVIS) insider share acquisition by Simon Biddiscombe an exempt transaction?

Yes. The filing states the purchase is intended to be an exempt transaction under Rule 16b-3. That rule generally allows certain insider transactions with the issuer to avoid short-swing profit recovery, when structured and approved in a compliant manner.

How did Simon Biddiscombe acquire the new MicroVision (MVIS) shares reported on Form 4?

He acquired the shares directly from MicroVision pursuant to a Subscription Agreement executed on March 15, 2026. The agreement provided for the purchase of 93,950 common shares at $0.5322, equal to the March 13, 2026 closing price.